Mayo clinic launches massive study on gut microbiome and cancer therapy

NCT ID NCT05112614

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study from Mayo Clinic is looking at how the bacteria in your gut (the microbiome) might influence how well cancer treatments work. Researchers will collect blood and stool samples from 3,000 cancer patients undergoing therapy or stem cell transplants. The goal is to find links between gut microbes and treatment outcomes, which could one day help doctors tailor cancer therapy to each patient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors personalize cancer therapy based on a patient's gut bacteria, potentially improving treatment effectiveness.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, and results may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic in Arizona

    ACTIVE_NOT_RECRUITING

    Scottsdale, Arizona, 85259, United States

  • Mayo Clinic in Florida

    ACTIVE_NOT_RECRUITING

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.